These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 19825097)

  • 1. Delayed hypersensitivity to Mitomycin C.
    Fernandez DG; Fernández AF; Vallejo MS; Osorio JL; Anguita MJ; Jimenez AL
    Contact Dermatitis; 2009 Oct; 61(4):237-8. PubMed ID: 19825097
    [No Abstract]   [Full Text] [Related]  

  • 2. Dermatological side effects of intravesical Mitomycin C: Delayed hypersensitivity.
    Colomer Gallardo A; Martínez Rodríguez R; Castillo Pacheco C; González Satue C; Ibarz Servio L
    Arch Esp Urol; 2016 Mar; 69(2):89-91. PubMed ID: 26959968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eosinophilic cystitis presenting as a recurrent symptomatic bladder mass following intravesical mitomycin C therapy.
    Clark T; Chang SS; Cookson MS
    J Urol; 2002 Apr; 167(4):1795. PubMed ID: 11912421
    [No Abstract]   [Full Text] [Related]  

  • 4. Pseudoscleroderma possibly induced by intravesical instillation of mitomycin C.
    Calistru AM; Baudrier T; Mota A; Alexandrescu D; Cunha AL; Silva J; Azevedo F
    J Am Acad Dermatol; 2010 Dec; 63(6):e116-8. PubMed ID: 21093658
    [No Abstract]   [Full Text] [Related]  

  • 5. [Lung sarcoidosis following instillation of mitomycin C in the urinary bladder].
    Cuervo Pinna MA; Cuervo Pinna C; Macías Castillo S; Bureo Dacal JC; Espada Alonso MJ; Pimentel Leo J
    An Med Interna; 2001 Dec; 18(12):641-3. PubMed ID: 11852501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Necrosis of the glans penis: a rare complication of intravesical therapy with mitomycin c.
    Neulander EZ; Lismer L; Kaneti J
    J Urol; 2000 Oct; 164(4):1306. PubMed ID: 10992393
    [No Abstract]   [Full Text] [Related]  

  • 7. Intravesical mitomycin C-induced generalized pustular folliculitis.
    Andreu-Barasoain M; Gómez de la Fuente E; Pinedo F; Nuño A; López-Estebaranz JL
    J Am Acad Dermatol; 2012 Oct; 67(4):e142-3. PubMed ID: 22980268
    [No Abstract]   [Full Text] [Related]  

  • 8. Type III and type IV hypersensitivity reactions due to mitomycin C.
    Kunkeler L; Nieboer C; Bruynzeel DP
    Contact Dermatitis; 2000 Feb; 42(2):74-6. PubMed ID: 10703627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generalized dermatitis due to mitomycin C patch test.
    Echechipía S; Alvarez MJ; García BE; Olaguíbel JM; Rodriguez A; Lizaso MT; Acero S; Tabar AI
    Contact Dermatitis; 1995 Dec; 33(6):432. PubMed ID: 8706407
    [No Abstract]   [Full Text] [Related]  

  • 10. Risk of post-operative intravesical mitomycin C instillation following transurethral bladder tumor resection.
    Shapiro O; Jones K; Wang C; Landas S; Haas GP
    Can J Urol; 2006 Dec; 13(6):3317-20. PubMed ID: 17187694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immediate administration of intravesical mitomycin C after tumour resection for superficial bladder cancer.
    Mostafid AH; Rajkumar RG; Stewart AB; Singh R
    BJU Int; 2006 Mar; 97(3):509-12. PubMed ID: 16469017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug eruption due to intravesical instillations of both epirubicin and mitomycin C.
    Okumura A; Oishi N; Kaji K; Imamura T; Fuse H
    J Dermatol; 2009 Jul; 36(7):419-22. PubMed ID: 19583691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravesical mitomycin C for superficial transitional cell carcinoma.
    Bolenz C; Cao Y; Arancibia MF; Trojan L; Alken P; Michel MS
    Expert Rev Anticancer Ther; 2006 Aug; 6(8):1273-82. PubMed ID: 16925493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electromotive drug administration with mitomycin C for intravesical treatment of non-muscle invasive transitional cell carcinoma.
    Kalsi J; Harland SJ; Feneley MR
    Expert Opin Drug Deliv; 2008 Jan; 5(1):137-45. PubMed ID: 18095933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic allergic contact dermatitis from intravesical instillation of the antitumor antibiotic mitomycin C.
    de Groot AC; Conemans JM
    Contact Dermatitis; 1991 Mar; 24(3):201-9. PubMed ID: 1831098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bladder wall fibrosis following intravesical mitomycin treatment for superficial bladder cancer.
    Katz G; Hackett RL; Wajsman Z
    Urology; 1996 Jun; 47(6):928-9. PubMed ID: 8677595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous complications of intravesical treatments for bladder cancer: granulomatous inflammation of the penis following BCG therapy and penile gangrene following mitomycin therapy.
    Kureshi F; Kalaaji AN; Halvorson L; Pittelkow MR; Davis MD
    J Am Acad Dermatol; 2006 Aug; 55(2):328-31. PubMed ID: 16844523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bilateral ureteric strictures after intravesical mitomycin C.
    Wass AR; Lawson TR; Urwin GH
    Br J Urol; 1993 Nov; 72(5 Pt 1):661-2. PubMed ID: 10071561
    [No Abstract]   [Full Text] [Related]  

  • 19. Laryngeal cancer after topical mitomycin C application.
    Agrawal N; Morrison GA
    J Laryngol Otol; 2006 Dec; 120(12):1075-6. PubMed ID: 17040596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interstitial pneumonitis: an exceptional toxicity of hyperthermic intraperitoneal mitomycin C.
    González-Moreno S; Lambert LA; Mansfield PF
    Eur J Surg Oncol; 2008 Apr; 34(4):482-4. PubMed ID: 17434283
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.